Medical Cannabis - Spain

Spain

Revenue in the Medical Cannabis market is projected to reach US$233.00m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.66%, resulting in a market volume of US$306.90m by 2029.
In global comparison, most revenue will be generated in the United States (US$14,530.00m in 2024).
In relation to total population figures, per person revenues of US$2.87k are generated in 2024.

Key regions: Spain, Europe, Australia, Germany, United States

Market

Region

Region comparison

Currency

Analyst Opinion

Spain has seen a significant growth in the Medical Cannabis market in recent years, driven by changing regulations and increasing acceptance of cannabis for medical purposes.

Customer preferences: Customers in Spain are showing a growing interest in alternative medical treatments, leading to a rise in demand for Medical Cannabis products. Many consumers are seeking natural remedies and are attracted to the potential health benefits that Medical Cannabis offers.

Trends in the market: One of the key trends in the Medical Cannabis market in Spain is the expanding product range. Companies are introducing a variety of Medical Cannabis products, including oils, tinctures, capsules, and topicals, to cater to different consumer preferences and needs. Additionally, there is a growing focus on research and development to create innovative and effective Medical Cannabis solutions.

Local special circumstances: Spain has a long history of cannabis consumption, both for recreational and medicinal purposes. This cultural acceptance of cannabis has played a role in the development of the Medical Cannabis market in the country. Furthermore, Spain's favorable climate allows for the cultivation of Medical Cannabis, contributing to the local production of high-quality products.

Underlying macroeconomic factors: The economic landscape in Spain, including factors such as increasing healthcare costs and a growing aging population, has also influenced the growth of the Medical Cannabis market. As more people seek alternative and cost-effective medical treatments, the demand for Medical Cannabis is expected to continue to rise. Additionally, the government's efforts to regulate and legalize the Medical Cannabis industry have provided a framework for market growth and investment.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.